MedTrace Logo

Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients

NCT01917851 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2013-08-07

No results posted yet for this study

Summary

The purpose of the study is to define the precision, accuracy and variability of the NBM-200 system in non invasive blood Hemoglobin (Hb) measurements relative to the laboratory blood analyzer by comparing two consecutive Hb values obtained by the NBM system to venous values.

Conditions

Sponsors & Collaborators

  • OrSense, Ltd.

    lead INDUSTRY

Principal Investigators

  • Eran Hadar, MD · Rabin Medical Center

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-08-31
Completion
2013-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917851 on ClinicalTrials.gov